TNF and cancer: While the study concluded that TNF-α antagonists did not significantly increase cancer risk in this population, it also suggests that any minor increase in overall cancer risk among patients exposed to TNF-α antagonists may be linked to concurrent azathioprine use rather than the antagonists themselves.